Figure 1.
Numbers and proportions of viral load tests included and excluded at each stage of the analysis of predictors of virological outcomes, Swaziland, 2012–2013.
Table 1.
Factors associated with detectable viral load (viral load >100 copies/ml) in patients on antiretroviral therapy for more than six months in Swaziland, 2012–2013.
Table 2.
Factors associated with viral re-suppression (viral load<100 copies/ml, or 2 log reduction) after planned adherence counselling in patients with detectable viral load on antiretroviral therapy in Swaziland, 2012–2013.